Freenome Inc (FRNM)

Currency in USD
13.81
+0.30(+2.22%)
Closed·
13.810.00(0.00%)
·
FRNM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.3314.13
52 wk Range
9.9514.47
Key Statistics
Prev. Close
13.51
Open
13.33
Day's Range
13.33-14.13
52 wk Range
9.95-14.47
Volume
735.07K
Average Volume (3m)
457.67K
1-Year Change
30.6528%
Book Value / Share
-125.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FRNM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.00
Upside
+30.34%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Freenome Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.00
(+30.34% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy21.00+52.06%-New CoverageAug 20, 2026
TD Cowen
Buy17.00+23.10%-New CoverageAug 18, 2026
BTIG
Buy17.00+23.10%-New CoverageAug 17, 2026
Jefferies
Buy17.00+23.10%-New CoverageAug 17, 2026

Earnings

Latest Release
Jul 15, 2026
EPS / Forecast
-0,01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FRNM Income Statement

Compare FRNM to Peers and Sector

Metrics to compare
FRNM
Peers
Sector
Relationship
P/E Ratio
−6.3x−0.8x−0.4x
PEG Ratio
-0.010.00
Price/Book
−1.1x1.7x2.6x
Price / LTM Sales
41.9x2.6x3.1x
Upside (Analyst Target)
23.1%2.4%48.9%
Fair Value Upside
Unlock17.1%6.2%Unlock

Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops blood-based tests, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
559,17K0,50%7,72M
Other Institutional Investors
65,73M58,24%907,68M
Public Companies & Retail Investors
46,57M41,27%643,16M
Total
112,86M100,00%1,56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
RA Capital Management, L.P.13,62%15 367 270212 222
RA Capital Healthcare Fund, L.P.10,84%12 230 122168 898

FAQ

What Is the Freenome (FRNM) Stock Price Today?

The Freenome stock price today is 13,81 USD.

What Stock Exchange Does Freenome Trade On?

Freenome is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Freenome?

The stock symbol for Freenome is "FRNM."

What Is the Freenome Market Cap?

As of today, Freenome market cap is 1,48B USD.

What Is Freenome's Earnings Per Share (TTM)?

The Freenome EPS (TTM) is -8,84.

From a Technical Analysis Perspective, Is FRNM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Freenome Stock Split?

Freenome has split 0 times.

How Many Employees Does Freenome Have?

Freenome has 378 employees.

What is the current trading status of Freenome (FRNM)?

As of Aug 23, 2026, Freenome (FRNM) is trading at a price of 13,81 USD, with a previous close of 13,51 USD. The stock has fluctuated within a day range of 13,33 USD to 14,13 USD, while its 52-week range spans from 9,95 USD to 14,47 USD.

What Is Freenome (FRNM) Price Target According to Analysts?

The average 12-month price target for Freenome is 18,00 USD, with a high estimate of 21 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +30,34% Upside potential.

What Is the FRNM Premarket Price?

FRNM's last pre-market stock price is 13,60 USD. The pre-market share volume is 490,00, and the stock has decreased by 0,09, or 0,67%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.